Join to View Full Profile
850 Columbia RdSte 108Westlake, OH 44145
Phone+1 440-808-1212
Fax+1 210-237-4807
Dr. Alkhouri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Pediatric Gastroenterology, 2007 - 2010
Albert Einstein Medical CenterResidency, Internal Medicine/Pediatrics, 2003 - 2007
Damascus University Faculty of MedicineClass of 2001
Certifications & Licensure
OH State Medical License 2007 - 2027
TX State Medical License 2017 - 2027
AZ State Medical License 2020 - 2026
PA State Medical License 2003 - 2007
American Board of Internal Medicine Internal Medicine
American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 4 citationsA phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH.Stephen A Harrison, Naim Alkhouri, Grisell Ortiz-Lasanta, Madhavi Rudraraju, Dean Tai
Journal of Hepatology. 2025-08-01 - Resmetirom for Steatotic Liver Disease: Does Data Support Widespread Use?Winston Dunn, Naim Alkhouri
Current Gastroenterology Reports. 2025-07-22 - MASLD in Patients with Chronic Hepatitis B Virus Infection: Hiding in Plain Sight.Naim Alkhouri, Jean-Michel Pawlotsky
Clinical Gastroenterology and Hepatology. 2025-07-21
Journal Articles
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications for Liver Transplant and Ethnic and Gender VariancesTsuyoshi Todo, Walid S Ayoub, Naim Alkhouri, Nicholas N Nissen, Vinay Sundaram, Shelly C Lu, Mazen Noureddin, Aarshi Vipani, Tram Tran, Andrew S Klein, Nature
Press Mentions
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™March 18th, 2025- PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024November 18th, 2024
- 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD the Liver Meeting® 2024November 15th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
